Black Rock Inc. Agios Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,658,095 shares of AGIO stock, worth $169 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,658,095
Previous 4,962,237
6.13%
Holding current value
$169 Million
Previous $111 Million
23.25%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$203 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$202 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$146 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$114 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.96MShares$108 Million1.18% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.99B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...